Intellia Therapeutics, Inc. (NTLA)

14.95 +0.79 (+5.58%) USD  |  NASDAQ  |  Apr 17, 16:00
14.62 -0.33 (-2.21%) After-Hours: 05:22
More

Intellia Therapeutics SG&A Expense (Quarterly) : 33.08M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. 33.66M
KalVista Pharmaceuticals, Inc. 61.00M
Beam Therapeutics, Inc. 32.28M
Personalis, Inc. 14.09M
Novavax, Inc. 34.12M